FAIM in Immunity and Autoimmunity

免疫和自身免疫中的 FAIM

• 批准号: 8489252
• 负责人: THOMAS L ROTHSTEIN
• 金额: $ 38.62万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8489252
• 关键词: Affect; Affinity; Antibodies; Antibody Formation; Antibody-Producing Cells; Antigens; Apoptosis; Attention; Autoantibodies; Autoimmune Diseases; Autoimmune Process; Autoimmunity; Autologous; B cell differentiation; B-Cell Activation; B-Lymphocytes; BCL1 Oncogene; Bacterial Infections; Binding; Biological Models; Biology; Blood; Cell physiology; Cellular biology; Clinical; Complex; DNA; Development; Disease; Down-Regulation; Dysplasia; Evolution; Face; Genes; Goals; Grant; Human; IRF4 gene; Immune; Immune response; Immunity; Immunoglobulins; In Vitro; Laboratories; Letters; Leukocytes; Location; Lower Organism; Lupus; Lupus Erythematosus; MS4A1 gene; Mature B-Lymphocyte; Modeling; Molecular Structure; Molecular Target; Mus; Participant; Patients; Personal Communication; Physiology; Plasma Cells; Play; Porifera; Process; Production; Protein Region; Proteins; Publishing; Research Personnel; Rest; Role; Sequence Homology; Signal Transduction; Specificity; Structure; Structure of germinal center of lymph node; System; TNFRSF5 gene; TNFSF5 gene; Time; Virus Diseases; Work; antimicrobial; fascinate; feeding; gene cloning; gene discovery; in vivo; lupus prone mice; new therapeutic target; novel; overexpression; plasma cell differentiation; public health relevance; therapeutic target; transcription factor

DESCRIPTION (provided by applicant): Like the two faces of Janus, antibodies can be a gateway to anti-microbial immunity or to autoantibody- associated disease. The recent successful use of anti-CD20 to treat patients with autoimmune dyscrasias has re-focused attention on the role of B cells as therapeutic targets. Mature B cells become antibody secreting plasma cells through a complex process that begins in the germinal center and involves alterations in multiple transcription factors. Work from this laboratory has identified a new player in B cell activation and differentiation, namely the novel gene, Faim. FAIM is unique; it is highly evolutionarily conserved, yet does not contain sequence homology, or structural homology, with any other protein. In B cells FAIM acts as a force multiplier. It boosts CD40 signaling by enhancing CD40L-stimulated increases in NF-:B and IRF4, and, it enhances the CD40L-stimulated decline in BCL-6. As expected from the extra increase in IRF4 and decline in BCL-6 (as well as its location in the germinal center) FAIM overexpression augments the plasma cell compartment in chimeric mice. FAIM expression is stimulated by IRF4 and so once triggered FAIM is involved in a "feed-forward" positive re-inforcing mechanism. The long term objective of this proposal is two-fold: to understand normal B cell biology focusing on how "resting" B cells become effectors, and to determine the points at which these processes go awry resulting in autoantibody production and autoimmunity. The near term objective of this work is to define the role of FAIM in facilitating immunity and regulating autoimmunity, with the goal of identifying a new therapeutic target. The specific aims of this proposal are to: 1) conduct a careful molecular structure/function analysis to identify and characterize the unique FAIM effector motif; and, 2) evaluate the influence of FAIM on the quality and selection of antibody produced in a model normal immune response, and on checkpoint integrity in a model system of spontaneous autoantibody production, and elucidate the physiology of FAIM expression in the germinal center. The results of this work are highly likely to provide completely new and fundamental information about how signaling in B cells is promoted, and about how plasma cell differentiation is regulated. Moreover, the recent finding by other investigators (unpublished) that SNPs proximal to, and within, the FAIM sequence are strongly associated with human lupus disease indicates that the mechanisms revealed by this study are highly likely to be relevant to understanding clinical autoimmunity and may provide a new target for therapeutic manipulation.

描述（由申请人提供）：与两面神一样，抗体可以是抗微生物免疫或自身抗体相关疾病的门户。最近成功地使用抗-CD 20治疗患有自身免疫性恶液质的患者使人们重新关注B细胞作为治疗靶点的作用。成熟的B细胞通过一个复杂的过程变成分泌抗体的浆细胞，该过程始于生发中心并涉及多种转录因子的改变。该实验室的工作已经确定了B细胞活化和分化中的新参与者，即新基因Faim。FAIM是独特的;它是高度进化保守的，但不包含与任何其他蛋白质的序列同源性或结构同源性。在B细胞中，FAIM充当力倍增器。它通过增强CD 40 L刺激的NF-：B和IRF 4的增加来增强CD 40信号传导，并且它增强CD 40 L刺激的BCL-6的下降。正如从IRF 4的额外增加和BCL-6的下降（以及其在生发中心的位置）所预期的，FAIM过表达增加了嵌合小鼠中的浆细胞区室。FAIM表达受IRF 4刺激，因此一旦触发FAIM，FAIM参与“前馈”正向再强化机制。该提案的长期目标是双重的：了解正常B细胞生物学，重点是“静息”B细胞如何成为效应子，并确定这些过程出错导致自身抗体产生和自身免疫的点。这项工作的近期目标是确定FAIM在促进免疫和调节自身免疫方面的作用，目标是确定新的治疗靶点。本研究的具体目标是：1）进行仔细的分子结构/功能分析，以鉴定和表征独特的FAIM效应基序;和2）评估FAIM对正常免疫应答模型中产生的抗体的质量和选择的影响，以及对自发自身抗体产生模型系统中检查点完整性的影响，并阐明FAIM在生殖中心表达的生理学。这项工作的结果极有可能提供关于B细胞中信号传导如何被促进以及浆细胞分化如何被调节的全新和基本的信息。此外，其他研究人员最近发现（未发表）FAIM序列附近和内部的SNP与人类狼疮疾病密切相关，表明本研究揭示的机制很可能与理解临床自身免疫相关，并可能为治疗操作提供新的靶点。